Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02018146 · ClinicalTrials.gov registry record · NA
Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02018146: Completed NA study, sponsored by University of Louisville.
NCT02018146 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02018146, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
Failed mask ventilation poses an increased risk of de-oxygenation to the patient undergoing general anesthesia. Nasopharyngeal ventilation may be a valid alternative for mask ventilation allowing for better oxygenation during the induction phase of general anesthesia. Oxygenation may be maintained better in case of difficult mask ventilation. This study evaluates this alternative method in comparison with the standard method of mask ventilation. General Design This is a randomized, controlled, cross over study. Patients will be randomized to mask ventilation followed by nasopharyngeal airway placement and ventilation or vice versa. Primary Study Endpoints We will test the hypothesis that ventilation via a nasally placed ETT is superior in its efficacy (as measured by tidal volume) to routine facemask ventilation in patients undergoing general anesthesia and endotracheal intubation for their surgery.
Primary Outcome
After facemask or nasopharyngeal ventilation
Interventions
- OTHER Mask then nasopharyngeal
- OTHER Nasopharyngeal then mask
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-05 |
| Phase | NA |
What the finished NCT02018146 record still lists
NCT02018146 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Mask then nasopharyngeal is the first listed.
NCT02018146 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02018146 about?
NCT02018146 is a clinical study titled "Cohort 2 Efficacy of Nasopharyngeal Ventilation With Endotracheal Tube for Surgery". Failed mask ventilation poses an increased risk of de-oxygenation to the patient undergoing general anesthesia. Nasopharyngeal ventilation may be a valid alternative for mask ventilation allowing for better oxygenation during the induction phase of general anesthesia. Oxygenation may be maintained b...
What is the current status of trial NCT02018146?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-06. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02018146?
The interventions under investigation include: Mask then nasopharyngeal (OTHER), Nasopharyngeal then mask (OTHER).
Who is sponsoring clinical trial NCT02018146?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02018146's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia